cckinase, Inc.

Favorite  |  Set Home
E-mail: info@cckinase.com
Products > JAK/STAT Signaling > JAK > Pacritinib (SB1518; SB 1518; SB-1518)
Pacritinib (SB1518; SB 1518; SB-1518)
Product name : Pacritinib (SB1518; SB 1518; SB-1518)
Product No. : cs-914
Price : 100mg, $475, 500mg/$1275
CAS : 
Bulk inquiry : 
←[Previous Product]              [Next Product]→
Online Inquiry         Email Us

  Details:
Pacritinib (CAS: 937272-79-2) is a potent inhibitor of both wild-type JAK2 (IC50=23 nM) and JAK2V617F mutant (IC50=19 nM). Pacritinib also inhibits FLT3 (IC50=22 nM) and its mutant FLT3D835Y (IC50=6 nM). Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK-STAT signaling pathway, and so caspase-dependent apoptosis. JAK2 is the most common mutated gene in bcr-abl-negative myeloproliferative disorders.

  Related Products :

BMS-911543 (BMS911543, BMS 911543)
BMS-911543 (BMS911543, BMS 911543)
Price: 100mg, $675, 500mg/$1875

GLPG0634 (analog)
GLPG0634 (analog)
Price: 100mg, $675, 500mg/$1875

Decernotinib (VX-509; VX509; VX 509; VRT-831509)
Decernotinib (VX-509; VX509; VX 509; VRT-831509)
Price: 100mg, $675, 500mg/$1875

JANEX-1 (WHI-P131)
JANEX-1 (WHI-P131)
Price: 100mg/$675; 500mg/$1875

Cerdulatinib (PRT062070; PRT2070; PRT-062070; PRT-2070; PRT 062070; PRT 2070)
Cerdulatinib (PRT062070; PRT2070; PRT-062070; PRT-2070; PRT 062070; PRT 2070)
Price: 100mg, $475, 500mg/$1275

JAK2 Inhibitor V, Z3 (NSC-42834, NSC42834, NSC 42834)
JAK2 Inhibitor V, Z3 (NSC-42834, NSC42834, NSC 42834)
Price: 100mg, $975, 500mg/$2475

SAR-20347 (SAR20347, SAR 20347)
SAR-20347 (SAR20347, SAR 20347)
Price: 100mg/$675; 500mg/$1875

ZM39923 (ZM-39923)
ZM39923 (ZM-39923)
Price: 100mg, $475, 500mg/$1275

Online service

info@cckinase.com